| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| IL-1 beta | HOT ILB-H4110 | Human IL-1 beta / IL-1F2 Protein, premium grade | Human | E. coli | ![]() | HPLCSDS-PAGE | $190.00 20ug | |
| IL-1 beta | HOT ILB-M51H3 | Mouse IL-1 beta / IL-1F2 Protein, His Tag (MALS verified) | Mouse | E. coli | ![]() | MALSSDS-PAGE | $165.00 20ug | |
| IL-1 beta | Human IL-1 beta / IL-1F2 Protein, His Tag (MALS verified) | Human | E. coli | ![]() | MALSSDS-PAGE | $190.00 20ug | ||
| IL-1 beta | HOTAvitag ILB-H82E9 | Biotinylated Human IL-1 beta / IL-1F2 Protein, His,Avitag™ (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $430.00 25ug | |
| IL-1 beta | HOTDMF GMP-ILBH16 | GMP Human IL-1 beta Protein | Human | E. coli | ![]() | MSSDS-PAGE | $625.00 50ug | |
| IL-1 beta | Human IL-1 beta / IL-1F2 Protein, Fc Tag (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $165.00 20ug | ||
| IL-1 beta | Cynomolgus IL-1 beta / IL-1F2 Protein, His Tag | Cynomolgus | E. coli | ![]() | SDS-PAGE | $165.00 20ug | ||
| IL-1 beta | Human IL-1 beta / IL-1F2 Protein, Research Grade | Human | E. coli | ![]() | HPLCSDS-PAGE | $149.00 20ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Ensereptide | PXL-01 | Phase 3 Clinical | Promore Pharma | Cicatrix; Post-surgical adhesions; Tissue Adhesions | Details |
| Efprezimod alfa | CD24-Fc; HAS-CD24; CD24-Fc-IgG; MK-7110; MK7110 | Phase 3 Clinical | Oncoimmune Inc | Coronavirus Disease 2019 (COVID-19); Dyslipidemias; Graft vs Host Disease; Hematopoietic stem cell transplantation (HSCT); HIV Infections; Leukemia; Leukemia, Myeloid, Acute; Melanoma; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Solid tumours | Details |
| Lutikizumab | ABT-981 | Phase 3 Clinical | Abbvie Inc | Colitis, Ulcerative; Crohn Disease; Dermatitis, Atopic; Hidradenitis Suppurativa; Osteoarthritis; Osteoarthritis, Knee | Details |
| Goflikicept | RPH-104 | Phase 3 Clinical | Trpharm | Arthritis, Gouty; Coronavirus Disease 2019 (COVID-19); Familial Mediterranean Fever; Gout; Pancreatitis; Pericarditis; Schnitzler Syndrome; ST Elevation Myocardial Infarction; Still's Disease, Adult-Onset | Details |
| KPL-387 | KPL-387 | Phase 3 Clinical | Kiniksa Pharmaceuticals Ltd | Heart Diseases; Pericarditis | Details |
| Canakinumab biosimilar (GENERIUM Pharmaceuticals) | GNR-086 | Phase 3 Clinical | Generium Pharmaceuticals | Arthritis, Juvenile; Still's Disease, Adult-Onset | Details |
| Arumakimig | MAS825; MAS-825 | Phase 3 Clinical | Novartis Pharmaceuticals Corp | Autoimmune Lymphoproliferative Syndrome; Coronary Disease; Coronavirus Disease 2019 (COVID-19); Enterocolitis; Still's Disease, Adult-Onset | Details |
| AVTX-009 | FL-101; AVTX-009; LY-2189102 | Phase 2 Clinical | Eli Lilly And Company | Arthritis, Rheumatoid; Autoimmune Diseases; Carcinoma, Non-Small-Cell Lung; Diabetes Mellitus, Type 2; Hidradenitis Suppurativa; Urinary Bladder Neoplasms | Details |
| CU-06 | CU-06-EYE; CU-06-IBD; CU-061004; Sac-1004; CU-06-ONCO; CU-06-HAE; CU06-1004 | Phase 2 Clinical | Curacle Co Ltd | Angioedemas, Hereditary; Colitis, Ulcerative; Crohn Disease; Diabetic macular oedema; Diabetic Retinopathy; Lung Diseases; Macular Degeneration; Myocardial Infarction; Neoplasms; Stroke | Details |
| ABBV-9832 | ABBV-9832 | Phase 2 Clinical | Abbvie Inc | Arthritis, Rheumatoid | Details |
| ABBV-166 | ABBV-166 | Phase 2 Clinical | Abbvie Inc | Arthritis, Psoriatic; Crohn Disease | Details |
| IL1-beta receptor antagonist Therapy(Hamlet BioPharma) | Phase 2 Clinical | Hamlet BioPharma AB | Cystitis; Pain | Details | |
| Gevokizumab | XMA-005.2; AB-7; XOMA-052; S-78989; VPM-087; XMA-0052 | Phase 1 Clinical | Xoma Corp | Acne Vulgaris; Arthritis, Rheumatoid; Behcet Syndrome; Carcinoma, Renal Cell; Colonic Neoplasms; Colorectal Neoplasms; Cryopyrin-Associated Periodic Syndromes; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Esophageal Neoplasms; Hereditary Autoinflammatory Diseases; Labyrinth Diseases; Osteoarthritis; Panuveitis; Pyoderma Gangrenosum; Stomach Neoplasms; Uveitis | Details |
| GenSci-161 | GenSci-161 | Phase 1 Clinical | Changchun GeneScience Pharmaceuticals Co Ltd | Endometriosis; Hidradenitis Suppurativa | Details |
| Diacerein ointment (TWi Biotechnology) | AC-203 | Phase 1 Clinical | Twi Biotechnology Inc | Epidermolysis Bullosa; Pemphigoid, Bullous | Details |
| DLX-2323 | DLX-2323 | Phase 1 Clinical | Delenex Therapeutics Ag | Inflammation | Details |
| Tavo-103 | Tavo103; Tavo-103; TAVO-103A; TAVO103A | Phase 1 Clinical | Tavotek Biotherapeutics (Hong Kong) Ltd | Details |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Canakinumab | ACZ-885 | Approved | Novartis Pharma Ag | Ilaris | United States | Muckle-Wells Syndrome (MWS); Cryopyrin-Associated Periodic Syndromes | Novartis Pharma Ag | 2009-06-17 | Alzheimer Disease; Anemia; Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid; Atherosclerosis; Behcet Syndrome; Carcinoma, Non-Small-Cell Lung; Cardiovascular Diseases; Chronic Urticaria; Cognitive Dysfunction; Coronavirus Disease 2019 (COVID-19); Cryopyrin-Associated Periodic Syndromes; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Familial Mediterranean Fever; Gout; Hepatitis, Alcoholic; Hereditary Autoinflammatory Diseases; Hyperimmunoglobulin D syndrome; Inflammation; Lung Neoplasms; Mevalonate Kinase Deficiency; Muckle-Wells Syndrome (MWS); Mucocutaneous Lymph Node Syndrome; Muscular Dystrophy, Duchenne; Myelodysplastic Syndromes; Peripheral Arterial Disease; Polyarticular Juvenile Idiopathic Arthritis; Polycythemia Vera; Prediabetic State; Primary Myelofibrosis; Pulmonary Disease, Chronic Obstructive; Pyoderma Gangrenosum; Sarcoidosis, Pulmonary; Schnitzler Syndrome; Still's Disease, Adult-Onset; | Details |
| PG-201 | PG-201 | Approved | Viromed | Layla | South Korea | Osteoarthritis | Pmg Pharm Co Ltd | 2012-01-01 | Osteoarthritis; Osteoarthritis, Knee | Details |
| Edaravone/(+)-2-Decanol | SIM-071201 | Approved | Jiangsu Simcere Pharmaceutical Co Ltd | 三贝心, 三贝欣, 先必新, Sanbexin | Mainland China | Stroke | Nanjing Simcere Dongyuan Pharmaceutical Co Ltd | 2020-07-29 | Alzheimer Disease; Amyotrophic Lateral Sclerosis; Brain Infarction; Cerebral Hemorrhage; Cognition Disorders; Ischemic Stroke; Stroke | Details |
| Diacerein | KW-4800; SF-277; Art-50 | Approved | Cartivix, Fisiodar, Verboril, Art, 安必丁, Artrodar, Artrolyt | Coronavirus Disease 2019 (COVID-19); Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Epidermolysis Bullosa; Insulin Resistance; Metabolic Dysfunction-Associated Steatotic Liver Disease; Obesity; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Overweight | Details | |||||
| Firsekibart | GenSci-048; GenSci048 | Approved | Changchun GeneScience Pharmaceuticals Co Ltd | 金蓓欣 | Mainland China | Arthritis, Gouty | Changchun GeneScience Pharmaceuticals Co Ltd | 2025-06-30 | Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid; Endometriosis; Gout; Lung Diseases, Interstitial; Pain; Solid tumours; Still's Disease, Adult-Onset; systemic sclerosis-associated interstitial lung disease | Details |
| Metaxalone (Primus Pharmaceuticals) | Approved | Primus Pharmaceuticals Inc | United States | Muscle Spasticity | Primus Pharmaceuticals Inc | 2015-06-01 | Muscle Spasticity | Details | ||
| Andrographolide/Sodium Hydrogen Sulfite | Approved | Bacterial Infections | Details | |||||||
| Edaravone/(+)-2-Decanol (Yantai Yene/Simcere) | Y-2 | Approved | Simcere Pharmaceutical Group Ltd, Yantai Yene Pharma Co Ltd | Mainland China | Stroke | Jiangsu Simcere Pharmaceutical Co Ltd | 2024-12-01 | Cerebral Hemorrhage; Cognitive Dysfunction; Intracranial Hemorrhages; Ischemic Stroke; Stroke | Details | |
| Rilonacept | KPL-914; RGN-303 | Approved | Regeneron Pharmaceuticals Inc | Arcalyst, 炎朵 | United States | Cryopyrin-Associated Periodic Syndromes | Kiniksa Pharmaceuticals Ltd | 2008-02-27 | Anemia; Arthritis, Juvenile; Atherosclerosis; Coronary Artery Disease; Cryopyrin-Associated Periodic Syndromes; Deficiency of interleukin-1 receptor antagonist; Diabetes Mellitus, Type 1; Familial Mediterranean Fever; Genetic Diseases, Inborn; Gout; Hearing Loss, Sensorineural; Inflammation; Muckle-Wells Syndrome (MWS); Pericarditis; Renal Insufficiency, Chronic; Sarcoidosis; Schnitzler Syndrome; Scleroderma, Diffuse; Scleroderma, Systemic; Still's Disease, Adult-Onset; Urticaria; Vascular Diseases | Details |
| Thalidomide | NSC-66847; NSC-527179; K-17; FPF-300; FPF300 | Approved | Celgene Corp | Talizer, Thalidomide Celgene, Thalidomide Pharmion, Synovir, Thalomid, Thaled | Mainland China | Leprosy, Lepromatous; Multiple Myeloma | Changzhou Pharmaceutical Factory | 1982-01-01 | Acquired Immunodeficiency Syndrome; Adenocarcinoma, Clear Cell; Adenoma, Islet Cell; Amyotrophic Lateral Sclerosis; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Anemia, Sideroblastic; Angiodysplasia; Appendiceal Neoplasms; Arachnoiditis; Arteriovenous Malformations; Axial Spondyloarthritis; beta-Thalassemia; Burning Mouth Syndrome; Carcinoid Tumor; Carcinoma, Adenosquamous; Carcinoma, Hepatocellular; Cholangitis, Sclerosing; Colorectal Neoplasms; Cough; Endometrial Neoplasms; Endometriosis; Epilepsy; Erythema Nodosum; Gastric Antral Vascular Ectasia; Gastrointestinal Hemorrhage; Genetic Diseases, Inborn; Glioma; Graft vs Host Disease; Head and Neck Neoplasms; Hemoglobinopathies; HIV Infections; HIV Wasting Syndrome; Hodgkin Disease; Hormone-Resistant Prostate Neoplasms; Hypertension, Portal; Idiopathic Pulmonary Fibrosis; Kidney Neoplasms; Leiomyosarcoma; Leprosy, Lepromatous; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelomonocytic, Chronic; Liver Neoplasms; Lung Neoplasms | Details |
